Overview

Bexarotene With Narrow-Band UVB for Psoriasis

Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
To determine if bexarotene gel with NBUVB phototherapy is more effective than placebo plus NBUVB for moderate to severe plaque-type psoriasis.
Phase:
Phase 2
Details
Lead Sponsor:
University of Medicine and Dentistry of New Jersey
Collaborator:
Ligand Pharmaceuticals
Treatments:
Bexarotene